Chihiro Yamamoto

Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older

Akiko Meguro, Katsutoshi Ozaki, Kazuya Sato et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 43 citations

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation

Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda et al. · Blood Advances · 2019 · 37 citations · Full text

Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies

Daisuke Minakata, Shin‐ichiro Fujiwara, Takashi Ikeda et al. · International Journal of Hematology · 2018 · 36 citations

Thrombosis, Venous Thrombosis, Laboratory Hematology +12

The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies

Tamotsu Tsukahara, N Iwase, Koichi Kawakami et al. · Gene Therapy · 2014 · 32 citations · Full text

B-cell Malignancies, Autoimmune Disease, Adaptive Immune System +9

Eosinophilia in premature infants: correlation with chronic lung disease

Chihiro Yamamoto, Takahiro Kojima, K Hattori et al. · Acta Paediatrica · 1996 · 32 citations

Asthma, Ecp Levels, Premature Infants +12